Every 10-Q that Nuburu, Inc. (BURU) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow BURU and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BURU filings page.
Nuburu, Inc. (BURU) restated its June 30, 2026 quarter to correct the fair value of the Tekne Convertible Note Receivable, with no impact on net cash flows. Management and the Audit Committee concluded this error reflects a material weakness in internal control over financial reporting, which the company plans to remediate by adding staff, training, and new procedures.
For the quarter, Nuburu generated $524,927 of revenue but reported a net loss of $5.7 million, and a $6.2 million loss for the first half of 2026, leaving an accumulated deficit of $206.7 million. Cash and cash equivalents fell to $726,934 from $24.7 million at year-end, and net cash used in operating activities was $15.1 million in the first half, prompting management to state that substantial doubt remains about Nuburu’s ability to continue as a going concern. Stockholders’ equity improved to $10.1 million from a deficit due to capital actions and acquisitions of Orbit and Lyocon, but the company faces NYSE American notices for equity and price noncompliance, a July 2026 delisting to OTC, and has executed 1‑for‑4.99 and 1‑for‑40 reverse stock splits to address minimum price requirements.
Nuburu, Inc. is repositioning as a dual‑use defense and security platform, consolidating new businesses while still operating at a loss and facing liquidity pressure. For the quarter ended June 30, 2026, it generated $524,927 of revenue (first half $932,571) and recorded a net loss of $6.5 million (first half $6.9 million). Operating expenses were $5.4 million in the quarter as the company invests in R&D, selling and marketing, and public‑company overhead.
Total assets rose to $68.4 million, reflecting the consolidation of Orbit and Lyocon and investments in Tekne and related parties. Stockholders’ equity improved from a deficit of $(15.2 million) at December 31, 2025 to positive equity of $9.4 million, helped by equity issuances, warrant exercises, debt extinguishments and non‑cash consideration in acquisitions.
Liquidity remains strained: cash and cash equivalents were only $726,934 (plus $875,141 restricted) at June 30, 2026, and operating activities used $15.1 million of cash in the first half. The company discloses substantial doubt about its ability to continue as a going concern and relies on external financing, including a standby equity purchase agreement. Nuburu is also working under an NYSE American compliance plan, and its common stock was delisted from NYSE American in July 2026 and now trades on the OTC market while it pursues an appeal and plans a reverse stock split.
Nuburu, Inc. reported a net loss of $459,898 for the three months ended March 31, 2026, a sharp improvement from a $16.6 million loss a year earlier, helped by large non‑operating fair value gains on warrants and debt. Revenue was modest at $407,644, generating a gross loss as operating expenses reached $7.7 million.
Total assets rose to $76.1 million, driven by new investments, goodwill and intangibles from the Orbit and Lyocon transactions and Tekne-related investments. Stockholders’ equity improved from a deficit of $(15.2) million at year‑end 2025 to positive equity of $2.2 million, while cash and cash equivalents fell to $8.3 million after heavy operating and investing cash outflows.
The company has adopted a new defense and security platform strategy, consolidating Orbit and acquiring Lyocon, and executed a 1‑for‑4.99 reverse stock split in February 2026. Despite these actions, management states that substantial doubt about Nuburu’s ability to continue as a going concern remains, citing ongoing losses, negative operating cash flows, significant debt obligations and dependence on external financing. Nuburu also remains under NYSE American continued listing deficiency notices and must regain required equity levels by October 29, 2026 under an accepted compliance plan.
Nuburu, Inc. (BURU) filed its Q3 2025 report, highlighting continued losses and liquidity strain. The company reported a net loss of $22.4 million for the quarter and a loss from operations of $2.62 million, with no revenue recognized. Cash and cash equivalents were $5.94 million, while total liabilities rose to $67.0 million, contributing to a stockholders’ deficit of $53.9 million.
Management disclosed “substantial doubt” about the company’s ability to continue as a going concern. Earlier in 2025, Nuburu wrote down inventory, property and equipment, and its lease right‑of‑use asset to zero after losing access to its facility, and recorded large non‑operating charges, including losses tied to warrants, notes, and a SEPA. The company received an NYSE American notice of noncompliance but has an accepted plan period through October 29, 2026; shares continue trading with a “.BC” designation. As of November 10, 2025, common shares outstanding were 433,644,251.
Nuburu, Inc. reported substantial non-cash impairments and financing activity in the quarter. Management wrote inventory to a net realizable value of $0, fully impaired property and equipment at a leased location, and fully impaired the related operating lease right-of-use asset, recording those losses in the condensed consolidated statement of operations for the six months ended June 30, 2025. The company recorded certain financial instruments at fair value using Level 3 inputs and determined its Public Warrants had no value as of June 30, 2025. The NYSE American notified the company that it was not in compliance with continued listing standards, although trading remains ongoing under the symbol BURU with a noncompliance designation. The company completed multiple convertible note financings and other capital infusions (including Indigo Capital, Brick Lane, Bomore, Diagonal, Boot and others) with varying terms, conversion prices tied to VWAP metrics, and several high-cost notes (for example, an Agile Note bearing 44% interest). The company entered a SEPA commitment providing access to up to $100 million of Common Stock sales and issued 1,332,623 commitment-fee shares during Q2 2025. Significant preferred stock remeasurement increased a mandatorily redeemable liability to $23,889,050, generating a $10,398,050 adjustment to net loss available to common shareholders for the six months ended June 30, 2025.